Genomic Health, Inc. (GHDX) Tops Q2 EPS by 8cm, Offers Q3 Rev. Guidance

August 8, 2012 4:42 PM

Genomic Health, Inc. (NASDAQ: GHDX) reported Q2 EPS of $0.06, $0.08 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found